The development of robust suspension cultures of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) without the use of cell membrane disrupting enzymes or inhibitors remains a significant challenge for the production of cell sources for regenerative therapies, drug screening, tissue engineering, and the study of disease progression.